Jean‐Philippe Foy

The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade

Jean‐Philippe Foy, Chloé Bertolus, Marie‐Cécile Michallet et al. · Annals of Oncology · 2017 · 92 citations · Full text

Cancer Immunosurveillance, Immune Microenvironment, Pd1/pd-l1 Blockade +10

New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development

Jean‐Philippe Foy, Curtis R. Pickering, Vassiliki A. Papadimitrakopoulou et al. · Cancer Prevention Research · 2015 · 75 citations · Full text

Chromatin, Percent Methylation, Genetics +15

Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients

Jean‐Philippe Foy, Andy Karabajakian, Sandra Ortiz‐Cuaran et al. · European Journal of Cancer · 2022 · 62 citations

Cancer Immunosurveillance, Medicine, Immunology +10

A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes

Jean‐Philippe Foy, Louis Bazire, Sandra Ortiz‐Cuaran et al. · BMC Medicine · 2017 · 50 citations · Full text

Immunological and classical subtypes of oral premalignant lesions

Jean‐Philippe Foy, Chloé Bertolus, Sandra Ortiz‐Cuaran et al. · OncoImmunology · 2018 · 47 citations · Full text